Moderate aortic stenosis is increasingly recognized as a disease entity with poor prognosis. Diagnosis of moderate aortic stenosis may be complemented by laboratory tests and advanced imaging techniques focused at detecting signs of cardiac damage such as increase of cardiac enzymes (N-terminal pro-B-type Natriuretic Peptide, troponin), left ventricular remodeling (hypertrophy, reduced left ventricular ejection fraction), or myocardial fibrosis. Therapy should include guideline-directed optimal medical therapy for heart failure. Patients with signs of cardiac damage may benefit from early intervention, which is the focus of several ongoing randomized controlled trials. As yet, no evidence-based therapy exists to halt the progression of aortic valve calcification.
Keyphrases
- aortic stenosis
- left ventricular
- poor prognosis
- heart failure
- aortic valve replacement
- ejection fraction
- aortic valve
- transcatheter aortic valve implantation
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- randomized controlled trial
- acute myocardial infarction
- risk assessment
- transcatheter aortic valve replacement
- high intensity
- high resolution
- mitral valve
- left atrial
- long non coding rna
- oxidative stress
- healthcare
- chronic kidney disease
- clinical trial
- coronary artery disease
- mass spectrometry
- heavy metals
- atrial fibrillation
- percutaneous coronary intervention
- stem cells
- climate change
- fluorescence imaging